Halozyme Therapeutics (HALO) News Today → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free HALO Stock Alerts $40.37 -0.49 (-1.20%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHALO Apr 2024 35.000 putfinance.yahoo.com - March 16 at 7:36 AMResearch Analysts Offer Predictions for Halozyme Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:HALO)americanbankingnews.com - March 15 at 7:54 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Expected to Earn Q1 2024 Earnings of $0.71 Per Sharemarketbeat.com - March 15 at 7:20 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells $416,400.00 in Stockamericanbankingnews.com - March 15 at 6:52 AMMichael J. Labarre Sells 10,000 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stockinsidertrades.com - March 14 at 9:38 AMInsider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells 10,000 Shares of Stockmarketbeat.com - March 13 at 7:34 PM7 Biotech Stocks to Buy as Sector Rotation Ramps Upinvestorplace.com - March 13 at 2:25 PMI:RUT Mar 2024 Weekly 1905.000finance.yahoo.com - March 12 at 9:17 AMAurora Investment Counsel Buys Shares of 35,261 Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 11 at 1:31 PMTD Cowen Reaffirms Their Buy Rating on Halozyme (HALO)markets.businessinsider.com - March 8 at 4:16 PMAdage Capital Partners GP L.L.C. Acquires Shares of 400,000 Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 8 at 7:27 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Kennedy Capital Management LLCmarketbeat.com - March 5 at 3:41 PMEnvestnet Asset Management Inc. Raises Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - March 4 at 5:01 AMTD Cowen Initiates Coverage of Halozyme Therapeutics (HALO) with Outperform Recommendationmsn.com - March 1 at 9:14 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Mariner LLCmarketbeat.com - March 1 at 5:32 AM3 Biotech Stocks for Sustainable Returnsstocknews.com - February 29 at 5:01 PMInsider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...finance.yahoo.com - February 29 at 9:44 AMTrexquant Investment LP Buys 13,258 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 29 at 7:46 AMClough Capital Partners L P Reduces Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 28 at 9:54 AMHalozyme to Participate in Upcoming Investor Conferencesprnewswire.com - February 27 at 8:30 AMConnor Clark & Lunn Investment Management Ltd. Has $6.61 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 26 at 8:18 AMAnalyst Estimates: Here's What Brokers Think Of Halozyme Therapeutics, Inc. (NASDAQ:HALO) After Its Full-Year Reportfinance.yahoo.com - February 23 at 7:45 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - February 23 at 1:43 AMFuller & Thaler Asset Management Inc. Grows Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 22 at 9:25 AMHalozyme Therapeutics Full Year 2023 Earnings: EPS Beats Expectationsfinance.yahoo.com - February 22 at 8:03 AMHalozyme Therapeutics Inc.money.usnews.com - February 21 at 3:54 PMBreaking Down Halozyme Therapeutics: 7 Analysts Share Their Viewsmarkets.businessinsider.com - February 21 at 10:47 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 21 at 10:47 AMHC Wainwright Raises Halozyme Therapeutics (NASDAQ:HALO) Price Target to $50.00marketbeat.com - February 21 at 8:12 AMCommonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 36,939 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 21 at 5:35 AMCompared to Estimates, Halozyme Therapeutics (HALO) Q4 Earnings: A Look at Key Metricsfinance.yahoo.com - February 20 at 11:43 PMHalozyme Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 20 at 6:44 PMHALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL AND OPERATING RESULTSfinance.yahoo.com - February 20 at 6:42 PMHalozyme Therapeutics Non-GAAP EPS of $0.82 misses by $0.01, revenue of $230.04M misses by $1.1Mmsn.com - February 20 at 6:42 PMHalozyme Therapeutics Inc (HALO) Reports Strong Year-Over-Year Growth in Q4 and Full Year 2023 ...finance.yahoo.com - February 20 at 6:42 PMHALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL AND OPERATING RESULTSprnewswire.com - February 20 at 4:01 PMEarnings Preview: Halozyme Therapeuticsbenzinga.com - February 19 at 12:56 PMHalozyme Therapeutics earnings preview: what Wall Street is expectingmarkets.businessinsider.com - February 19 at 12:56 PMHALO Jun 2024 22.500 putfinance.yahoo.com - February 17 at 6:05 PMHALO Jun 2024 30.000 putfinance.yahoo.com - February 17 at 1:04 PMHALO Jun 2024 40.000 putfinance.yahoo.com - February 17 at 8:04 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Short Interest Updatemarketbeat.com - February 16 at 6:46 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Canada Pension Plan Investment Boardmarketbeat.com - February 16 at 6:26 AMHalozyme Therapeutics (HALO) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measuresmsn.com - February 14 at 1:43 PMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Acquired by Charles Schwab Investment Management Inc.marketbeat.com - February 14 at 5:44 AMHalozyme Therapeutics (HALO) Scheduled to Post Quarterly Earnings on Tuesdaymarketbeat.com - February 13 at 5:35 AMCampbell & CO Investment Adviser LLC Makes New $591,000 Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 12 at 7:00 AMHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Mutual of America Capital Management LLCmarketbeat.com - February 11 at 7:51 AMWafra Inc. Takes $1.15 Million Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)marketbeat.com - February 9 at 5:53 PMHalozyme Therapeutics, Inc. Forecasted to Earn Q3 2024 Earnings of $0.85 Per Share (NASDAQ:HALO)marketbeat.com - February 9 at 7:20 AM Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address Like Tiny Crypto Retirement Funds (Ad)The crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. HALO Media Mentions By Week HALO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HALO News Sentiment▼0.230.64▲Average Medical News Sentiment HALO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HALO Articles This Week▼145▲HALO Articles Average Week Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EXEL News Today RLAY News Today ALLO News Today NVAX News Today FATE News Today ADPT News Today KOD News Today RGEN News Today NBIX News Today IMVT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HALO) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.